Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Xylem Addresses Industry Needs with Refractometers

Published: Wednesday, March 12, 2014
Last Updated: Thursday, March 13, 2014
Bookmark and Share
The Company’s Bellingham + Stanley brand RFM340+ refractometers help to meet the needs of the chemical and pharmaceutical industries with a combination of new technology and time-tested principles.

Despite the principles of measuring the refractive index (RI) of a solution dating back to the mid nineteenth Century, modern-day refractometers continue to play an important role in industry today, from chemical processing to pharmaceutical to automotive. As instruments get more sophisticated, they become more capable of measuring to higher accuracies, especially now that on-board temperature control is facilitated by intelligently controlled Peltier devices.  

One such application that is taking advantage of refractometer technology is within the chemical industry at a PVA monomer plant, where direct readout of sample concentration is simply displayed on the latest color display making interpretation by non-skilled operators far easier than before. The user defined scale (UDS) capability incorporated to the latest Bellingham + Stanley RFM340+ refractometer has provided efficient solutions where correlation between refractive index and the solids content of a PVA adhesive was established. This solution not only enabled the overall analysis time to be reduced significantly, but the level of operator skill and associated risk of error was diminished as well.
     
In another chemical processing application, the UDS capability on the refractometer also enabled the correlation of polymer solids to RI, to eliminate lengthy non-volatile solids testing and ultimately reducing costs in the process.  

Likewise, within a pharmaceutical industry application, a major European influenza vaccine producer turned to Bellingham + Stanley to provide replacement refractometers for their production plant. Due to the strict hygiene regulatory needs dictated by FDA regulation, special materials were applied to the wetted areas of the instrument, including PEEK sample presser, Kalrez® gasket materials and high grade stainless steel prism dish that was traceable in accordance with ISO 10204. The customer had utilized Bellingham + Stanley solutions for one of their previous instrument requirements, with great success, again with special materials fitted to the wetted areas in compliance with latest FDA regulations. Additionally, they had recently purchased a considerable number of PRH on-line refractometers for use at their facility in Dresden, Germany that is responsible for producing bird-flu vaccine.  


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 4,000+ scientific posters on ePosters
  • More than 5,300+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Making It Personal
Cancer vaccine linked to increased immune response against leukemia cells.
Improved Stability, Shelf Life of Protein Drugs
Study improves protein drug stability and extend their shelf life by tested a novel route for non-covalent protein modification.
More Effective Strategy for Producing Flu Vaccines
Researchers have developed a virus backbone, allowing producers to grow vaccine viruses in mammalian cells, rather than in eggs.
Improving Drug Production with Computer Model
A model has been developed that can be used to improve and accelerate the production of biotherapeutics, cancer drugs, and vaccines.
First New HIV Vaccine Study for Seven Years Begins
South Africa hosts historic clinical trial of experimental HIV vaccine aiming to safely prevent HIV infection.
Vaccination Against UTIs
Researchers have successfully vaccinated mice against E.coli growth in the bladder and kidneys.
First Steps to Neutralising Zika
Researchers have discovered a highly potent antibody that neutralises Zika infection at a cellular level.
Human Astrovirus Structure Could Lead to Therapies, Vaccines
Study shows where neutralizing antibody binds to human astrovirus, a leading cause of viral diarrhoea in children, elderly, and the immune-compromised.
Fighting Off HIV Infection Closer to Reality
Researchers have made significant progress in the development of a potential vaccine to protect against HIV infection.
Powerful New Tools to Combat Zika
Researchers have created a way to replicate the stucture of Zika virus, removing the genes that make the virus infectious.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
4,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,300+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!